Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acucela Inc.
Acucela Founder to Speak at Ophthalmology Conference
March 6th, 2009
Acucela founder and CEO Dr. Ryo Kubota will be a featured speaker at a symposium highlighting revolutionary pharmacotherapies in development and clinical practice to treat debilitating eye diseases, the company announced. Dr. Kubota has been invited to speak about clinical research associated with Acucela’s development of ACU-4429, an oral treatment for a condition known as age-related macular degeneration (AMD) that causes blindness in 30 million people worldwide. Acucela’s research focuses on halting the progress of dry AMD, the leading cause of blindness in people over 50. “Acucela is developing an innovative oral therapy to cure diseases that...
Source: Health Business Week (2009-03-06)
|
